2212-8778

Molecular Metabolism

Elsevier

View prefix report (10.1016)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2355 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2355 DOIs
2

Attach ORCID iDs across 1060 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact1060 DOIs
3

Deposit reference lists for 165 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact165 DOIs

DOIs for this ISSN

Showing the top 5 of 2355 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Glucagon-like peptide 1 (GLP-1) (10.1016/j.molmet.2019.09.010)
Abstract ORCID
161.08 1665
2 Ghrelin (10.1016/j.molmet.2015.03.005)
Abstract ORCID
149.02 955
3 Integrated physiology and systems biology of PPARα (10.1016/j.molmet.2014.02.002)
Abstract ORCID
139.79 624
4 Monocarboxylate transporters in cancer (10.1016/j.molmet.2019.07.006)
Abstract ORCID
137.91 572
5 Sex differences in lipid and lipoprotein metabolism (10.1016/j.molmet.2018.05.008)
Abstract ORCID
134.29 484
6 Metabolic dysfunction in polycystic ovary syndrome: Pathogen… (10.1016/j.molmet.2020.01.001)
Abstract ORCID
132.76 451
7 Distribution and characterisation of Glucagon-like peptide-1… (10.1016/j.molmet.2015.07.008)
Abstract ORCID
132.61 448
8 Muscle insulin sensitivity and glucose metabolism are contro… (10.1016/j.molmet.2013.10.005)
Abstract ORCID
130.05 398
9 Ketogenic diet in the treatment of cancer – Where do we stan… (10.1016/j.molmet.2019.06.026)
Abstract ORCID
129.94 396
10 JNK at the crossroad of obesity, insulin resistance, and cel… (10.1016/j.molmet.2016.12.001)
Abstract ORCID
128.70 374
11 Osteopontin: A novel regulator at the cross roads of inflamm… (10.1016/j.molmet.2014.03.004)
Abstract ORCID
127.75 358
12 Vascular effects of advanced glycation endproducts: Clinical… (10.1016/j.molmet.2013.11.006)
Abstract ORCID
124.36 306
13 Circadian control of glucose metabolism (10.1016/j.molmet.2014.03.002)
Abstract ORCID
123.64 296
14 Seven transmembrane G protein-coupled receptor repertoire of… (10.1016/j.molmet.2013.08.006)
Abstract ORCID
123.19 290
15 A guide to understanding endoplasmic reticulum stress in met… (10.1016/j.molmet.2021.101169)
Abstract ORCID
122.97 287
16 Insulin-like growth factors: Ligands, binding proteins, and… (10.1016/j.molmet.2021.101245)
Abstract ORCID
122.89 286
17 Insulin action, type 2 diabetes, and branched-chain amino ac… (10.1016/j.molmet.2021.101261)
Abstract ORCID
122.05 275
18 Optimal housing temperatures for mice to mimic the thermal e… (10.1016/j.molmet.2017.10.009)
Abstract ORCID
121.08 263
19 The sexually dimorphic role of adipose and adipocyte estroge… (10.1016/j.molmet.2013.05.006)
Abstract ORCID
119.63 246
20 Compartmentalised acyl-CoA metabolism and roles in chromatin… (10.1016/j.molmet.2020.01.005)
Abstract ORCID
119.55 245
21 Phosphoenolpyruvate carboxykinase in cell metabolism: Roles… (10.1016/j.molmet.2021.101257)
Abstract ORCID
118.46 233
22 The breadth of FGF21's metabolic actions are governed by FGF… (10.1016/j.molmet.2012.08.007)
Abstract ORCID
118.18 230
23 Identification of a novel mitochondrial uncoupler that does… (10.1016/j.molmet.2013.11.005)
Abstract ORCID
118.09 229
24 Astrocyte IKKβ/NF-κB signaling is required for diet-induced… (10.1016/j.molmet.2017.01.010)
Abstract ORCID
118.09 229
25 Diet-induced obesity promotes myelopoiesis in hematopoietic… (10.1016/j.molmet.2014.06.005)
Abstract ORCID
117.42 222
26 The diabetes medication Canagliflozin reduces cancer cell pr… (10.1016/j.molmet.2016.08.014)
Abstract ORCID
117.22 220
27 Fructose ingestion acutely stimulates circulating FGF21 leve… (10.1016/j.molmet.2014.09.008)
Abstract ORCID
116.92 217
28 Adipokines – removing road blocks to obesity and diabetes th… (10.1016/j.molmet.2014.01.005)
Abstract ORCID
116.72 215
29 NAFLD - A rising metabolic disease (10.1016/j.molmet.2021.101274)
Abstract References ORCID
116.72 35
30 Adiponectin, driver or passenger on the road to insulin sens… (10.1016/j.molmet.2013.04.001)
Abstract ORCID
116.52 213
31 Non-alcoholic fatty liver and the gut microbiota (10.1016/j.molmet.2016.06.003)
Abstract ORCID
116.32 211
32 Osteocalcin is necessary and sufficient to maintain muscle m… (10.1016/j.molmet.2016.07.002)
Abstract ORCID
115.80 206
33 Formate metabolism in health and disease (10.1016/j.molmet.2019.05.012)
Abstract ORCID
115.80 206
34 Demonstration of a day-night rhythm in human skeletal muscle… (10.1016/j.molmet.2016.06.012)
Abstract ORCID
115.59 204
35 GPR40 (FFAR1) – Combined Gs and Gq signaling in vitro is ass… (10.1016/j.molmet.2014.10.002)
Abstract ORCID
115.27 201
36 Sex differences in obesity, lipid metabolism, and inflammati… (10.1016/j.molmet.2018.04.003)
Abstract ORCID
114.83 197
37 Diabetic kidney diseases revisited: A new perspective for a… (10.1016/j.molmet.2019.10.005)
Abstract ORCID
114.83 197
38 CD36 promotes de novo lipogenesis in hepatocytes through INS… (10.1016/j.molmet.2021.101428)
Abstract ORCID
114.50 194
39 Dietary fat and gut microbiota interactions determine diet-i… (10.1016/j.molmet.2016.10.001)
Abstract ORCID
114.17 191
40 Biomarkers for type 2 diabetes (10.1016/j.molmet.2019.06.016)
Abstract ORCID
113.36 184
41 Inventing new medicines: The FGF21 story (10.1016/j.molmet.2013.12.003)
Abstract ORCID
112.76 179
42 Cardiomyocyte-specific deficiency of ketone body metabolism… (10.1016/j.molmet.2014.07.010)
Abstract ORCID
112.64 178
43 Action and therapeutic potential of oxyntomodulin (10.1016/j.molmet.2013.12.001)
Abstract ORCID
112.52 177
44 De novo lipogenesis in metabolic homeostasis: More friend th… (10.1016/j.molmet.2015.03.004)
Abstract ORCID
112.52 177
45 Not so hot: Optimal housing temperatures for mice to mimic t… (10.1016/j.molmet.2012.10.002)
Abstract ORCID
112.15 174
46 The glucoregulatory actions of leptin (10.1016/j.molmet.2017.04.011)
Abstract ORCID
112.03 173
47 Gut microbiota and immune crosstalk in metabolic disease (10.1016/j.molmet.2016.05.016)
Abstract ORCID
111.39 168
48 Inducible overexpression of adiponectin receptors highlight… (10.1016/j.molmet.2017.01.002)
Abstract ORCID
111.39 168
49 Causality of small and large intestinal microbiota in weight… (10.1016/j.molmet.2016.06.002)
Abstract ORCID
111.27 167
50 Tim-3 aggravates podocyte injury in diabetic nephropathy by… (10.1016/j.molmet.2019.02.007)
Abstract ORCID
110.87 164